GlassScriptPhysician profile
Charles S Grimshaw
NPI 1851590673
$88,725.83
in general payments reported to CMS, 2019-2025
25 companies · $434 in 2025
The $434 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $4,290 · 2021: $6,423 · 2022: $23K · 2023: $22K · 2024: $65.27 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Travel and Lodging: $1,650 · Food and Beverage: $979 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,119.19 |
| Travel and Lodging | $1,650.37 |
| Food and Beverage | $978.96 |
| Education | $199.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $87,277.32 | 2019-2025 | Juggerknotless Soft Anchor, Accufill, Gps III Platelet Concentration System |
| Stryker Corporation | $203.52 | 2022-2023 | Inspace, Augment Injectable, Mako |
| Pacira Therapeutics, INC. | $196.68 | 2019-2021 | |
| Seaspine Orthopedics Corporation | $153.97 | 2019-2021 | |
| Depuy Synthes Sales INC. | $133.13 | 2019-2024 | Monovisc |
| Smith+Nephew, INC. | $127.74 | 2025 | Tandem, Real Intelligence, Journey II |
| Elite Orthopedics, LLC | $111.91 | 2019-2024 | |
| Karl Storz Endoscopy-America | $85.33 | 2021 | |
| Heraeus Medical, LLC. | $60.15 | 2021-2023 | Palacos |
| Kci USA, INC. | $48.80 | 2021-2023 | V.A.C.Ulta, Prevena, 3m Duraprep Surgical |
| Heron Therapeutics, INC. | $44.30 | 2022 | |
| Radius Health, INC. | $35.47 | 2019-2020 | |
| Solventum Corporation | $31.12 | 2024 | Prevena |
| International Rehabilitative Sciences, INC | $25.28 | 2025 | Rs-4i Plus With Intersperse |
| Curonix LLC | $22.61 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $22.16 | 2022 | |
| Ferring Pharmaceuticals INC. | $22.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $21.41 | 2025 | Exparel |
| Fidia Pharma USA INC. | $19.63 | 2025 | Hyalgan |
| Vertex Pharmaceuticals Incorporated | $17.61 | 2025 | |
| Convatec INC. | $16.09 | 2019 | |
| Ethicon US, LLC | $13.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.97 | 2019 | |
| Arteriocyte Medical Systems, INC. | $11.70 | 2019 | |
| Wright Medical Technology, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Grimshaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.